Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis

Rheumatology International

Volumn 22, Issue 5, 2002, Pages 199-203

  Ringe, J ^a   Faber, H ^a   Bock, O ^b   Valentine, S ^b   Felsenberg, D ^b   Pfeifer, M ^c   Minne, H ^c   Schwalen, S ^d  

^a KLINIKUM LEVERKUSEN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Klinik der Fuerstenhof   (Germany)

^d JANSSEN CILAG GMBH   (Germany)

Author keywords

Analgesia; Fentanyl; Opioids; Osteoporosis; Pain

Indexed keywords

CALCIUM; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIPYRONE; ESTROGEN; FENTANYL; GESTAGEN; IBUPROFEN; PARACETAMOL; PHOSPHONIC ACID DERIVATIVE; VITAMIN D;

ADULT; AGED; ARTICLE; BACKACHE; BODY MOVEMENT; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OSTEOPOROSIS; PAIN ASSESSMENT; PATIENT SATISFACTION; PHYSIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; VERTEBRA FRACTURE; VERTIGO; VOMITING;

EID: 0036037748     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-002-0217-8     Document Type: Article

References (26)

1. A study of complaints and their relation to vertebral destruction in patients with osteoporosis
2. Time since vertebral fracture: An important variable concerning quality of life in patients with postmenopausal osteoporosis
3. Osteoporosis: A growing epidemic
4. Late physical activity and functional effects of osteoporotic fracture in women: The Rancho Bernardo Study
5. Clinical grading of spinal osteoporosis: Quality of life components and spinal deformity in women with vertebral osteoporosis
6. Reduced pulmonary function in patients with spinal osteoporotic fractures
7. Osteoporosis and low back pain
8. Medikamentöse schmerztherapie bei osteoporose
9. Transdermal fentanyl in the treatment of tumour pain. A prospective study in 42 subjects with malignant disorders
10. Transdermal fentanyl in cancer pain
11. Fentanyl transdermal system. Pain management at home
12. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control
13. Schmerztherapie bei osteoporose. Schwache opioide reichen nicht immer
14. Patienten-mobilisierung bei hochgradigen osteoporosen mit fentanyl-pflaster
15. Erfolgreiche schmerztherapie mit transdermalen opioiden
16. Biphosphonates: Mechanisms of action
17. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
18. Treatment of established corticoid-induced osteoporosis by 3-monthly intravenous ibandronate injections
19. Therapy with COX-2 inhibitors. Less risk - Better tolerance
20. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
21. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study. A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study
22. Quantitative estimation of rate adverse events which follow a biological progression: A new model applied to chronic NSAID use
23. Risk of cardiovascular events associated with selective COX-2 inhibitors